State of New Jersey Common Pension Fund D
STOK icon

State of New Jersey Common Pension Fund D’s Stoke Therapeutics STOK Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
11,954
-1,710
-13% -$54.9K ﹤0.01% 1651
2026
Q1 		$445K Buy
+13,664
New +$448K ﹤0.01% 1468

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State of New Jersey Common Pension Fund D's STOK Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Stoke Therapeutics (STOK) stake by 13% in Q2 2026, selling an estimated $54.9K and leaving 11,954 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

State of New Jersey Common Pension Fund D first reported a position in STOK in Q1 2026 and has held it in 2 quarters since. The position peaked at $445K in Q1 2026. 30 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 11,954 shares of Stoke Therapeutics worth $391K as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 1,710 Stoke Therapeutics shares in Q2 2026, an estimated $54.9K.
  • Stoke Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1651 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Stoke Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • State of New Jersey Common Pension Fund D's Stoke Therapeutics position peaked at $445K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.